Triangle singularity in the J/ψ→γpˉΔJ/\psi \to \gamma \bar{p} \Delta decay

In this work, we study the role of triangle singularity in the $J/\psi \to \gamma \bar{p} \Delta$ decay. We find that through a triangle mechanism, involving a triangle loop composed by $\omega$, $\pi$ and $p$, this decay may develop a triangle singularity and produce a visible peak in the invariant mass $M_{\gamma\Delta}$ around 1.73 GeV with a width of 0.02 GeV. Such a triangle mechanism may also cause significant spin effects on the final $\Delta$, which can be detected by measuring its spin density matrix elements. Our calculations show that the branching ratios due to the triangle mechanism is Br($J/\psi\to \gamma \bar p\Delta,\Delta\to \pi p$)=$1.058\times 10^{-6}$. Hopefully, this reaction can be investigated at BESIII and future experiments, e.g. Super Tau-Charm Facility, and the narrow width of the induced structure, the moving TS position and the distinct features of the spin density matrix elements of the $\Delta$ may serve as signals for the triangle singularity mechanism.Comment: 7 pages, 5 figure

Potential protective role of hydrogen against cisplatininduced side effects during chemotherapy: A mini-review of a novel hypothesis for antagonism of hydrogen

Purpose: To review the potential protective role of hydrogen against cisplatin-induced side effects during chemotherapy.Methods: We searched PubMed and SCOPUS using the following keywords and combinations in titles, keywords, abstracts and full texts: cisplatin; side effects; chemotherapy; tumor; toxicity; hydrogen; reactive oxidative species; and ischemic reperfusion.Results: The pathogenesis of cisplatin-induced side effects is suggested based on the increased level of reactive oxidative species (ROS). Cisplatin induces ROS-dependent platelet apoptosis via the extracellular signal-regulated kinase (ERK) signaling pathway, which might have contributed to cisplatininduced hematotoxicity, and in particular, thrombocytopenia. Molecular hydrogen has been shown to have therapeutic effects against damage to various organs (especially kidney, brain and liver) caused by ischemic reperfusion (IR) through selective elimination of the most cytotoxic ROS hydrogen radicals without affecting other types of ROS involved in signal transduction in vitro and in vivo.Conclusion: Hydrogen may not only alleviate hematotoxicity in patients with hemorrhagic tendencies during cisplatin-based chemotherapy, but also has a potential protective effect against other side effects induced by cisplatin.Keywords: Reactive oxygen species, Hydrogen radicals, Cisplatin, Hepatotoxicity, Chemotherapy, Side effects, Antagonis

Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy

<p>Abstract</p> <p>Background</p> <p>To evaluate the association between the clinical, dosimetric factors and severe acute radiation pneumonitis (SARP) in patients with locally advanced non-small cell lung cancer (LANSCLC) treated with concurrent chemotherapy and intensity-modulated radiotherapy (IMRT).</p> <p>Methods</p> <p>We analyzed 94 LANSCLC patients treated with concurrent chemotherapy and IMRT between May 2005 and September 2006. SARP was defined as greater than or equal 3 side effects and graded according to Common Terminology Criteria for Adverse Events (CTCAE) version 3.0.</p> <p>The clinical and dosimetric factors were analyzed. Univariate and multivariate logistic regression analyses were performed to evaluate the relationship between clinical, dosimetric factors and SARP.</p> <p>Results</p> <p>Median follow-up was 10.5 months (range 6.5-24). Of 94 patients, 11 (11.7%) developed SARP. Univariate analyses showed that the normal tissue complication probability (NTCP), mean lung dose (MLD), relative volumes of lung receiving more than a threshold dose of 5-60 Gy at increments of 5 Gy (V5-V60), chronic obstructive pulmonary disease (COPD) and Forced Expiratory Volume in the first second (FEV1) were associated with SARP (<it>p </it>< 0.05). In multivariate analysis, NTCP value (<it>p </it>= 0.001) and V10 (<it>p </it>= 0.015) were the most significant factors associated with SARP. The incidences of SARP in the group with NTCP > 4.2% and NTCP ≤4.2% were 43.5% and 1.4%, respectively (<it>p </it>< 0.01). The incidences of SARP in the group with V10 ≤50% and V10 >50% were 5.7% and 29.2%, respectively (<it>p </it>< 0.01).</p> <p>Conclusions</p> <p>NTCP value and V10 are the useful indicators for predicting SARP in NSCLC patients treated with concurrent chemotherapy and IMRT.</p